Journal of Endocrinological Investigation

, Volume 22, Issue 9, pp 660–665 | Cite as

Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: Results of a community-based study in northwestern Sardinia

  • A. Loviselli
  • A. Oppo
  • F. Velluzzi
  • F. Atzeni
  • G. L. Mastinu
  • P. Farci
  • G. Orgiana
  • A. Balestrieri
  • P. L. Cocco
  • S. Mariotti
Original Article


To assess the relationship between serological markers of thyroid autoimmunity and chronic hepatitis C, we surveyed the general population of two villages in the region of Sardinia, Italy, where infection with hepatitis viruses is endemic and the prevalence of autoimmune diseases is elevated. A total of 1310 subjects aged 6–88 years (65% of the total resident population) participated in the survey, and 1233 (94%; 444 males and 789 females) agreed to provide a blood sample. Autoantibodies to thyroid peroxidase (anti-TPO) were measured by radioimmunoassay; antibodies to HCV (anti-HCV) by a third generation enzyme immunoassay and borderline positive results confirmed by recombinant immunoblot assay. For both anti-HCV and anti-TPO the ageand gender-standardized prevalence rates (SPR) were calculated and the significance of the association between the two antibodies tested by Yates corrected χ2 test. The overall SPR for anti-HCV was 50.7×10−3 (86/1,233), similar between men [49.1×10−3 (22/444)] and women [52.3×10−3 (64/789)]. The overall SPR for anti-TPO was 136.9×10−3 (204/1,233), and that among women [201×10−3 (174/789)] was almost 3-fold that among men [71.6×10−3 (30/444)]. A concurrent anti-HCV and anti-TPO positivity was found in a small minority of subjects [8/1,233 (0.65%)], all women aged 57–81 years. The SPR for the two concurrent events was 3.3×10−3, which was not significantly different (Yates corrected χ2 test = 0.65) from that expected under the assumption of unrelated events. To explore whether HCV infection is a risk factor for anti-TPO positivity, we designed a casecontrol study with anti-TPO positive subjects as the cases, and anti-TPO negative subjects as the controls. The age- and gender-adjusted odd ratio (OR) was 0.4 (95% CI 0.2,0.7), indicating a negative association. In conclusion, no evidence for epidemiological association of circulating thyroid autoantibodies and antibodies to HCV was found. Our findings do not therefore support a pathogenetic link between HCV infection and thyroid autoimmunity.


Thyroid autoimmunity thyroid autoantibodies anti-thyroid peroxidase autoantibodies HCV infection anti-HCV antibodies HCV epidemiology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tomer Y., Davies T.F. Infections and autoimmune endocrine disease. Baillière Clin. Endocrinol. Metab. 1995, 9: 47–70.CrossRefGoogle Scholar
  2. 2.
    Huang M.J., Liaw Y.F. Clinical associations between thyroid and liver diseases. J. Gastroenterol. Hepatol. 1995, 10: 344–350.PubMedCrossRefGoogle Scholar
  3. 3.
    Tran A., Quaranta J.F., Benzaken S., Thiers V., Chau H.T., Hastier P., Regnier D., Dreyfus G., Pradier C., Sadoul J.L., Hebuterne X., Rampal P. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis- C before interferon therapy. Hepatology 1993, 18: 253.PubMedCrossRefGoogle Scholar
  4. 4.
    Pawlotsky J.M., Roudotthoraval F., Simmonds P., Mellor J., Benyahia M., Andre C., Voisin M.C., Intrator L., Zafrani E.S., Duval J., Dhumeaux D. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. Intern. Med. 1995, 122: 169–173.PubMedCrossRefGoogle Scholar
  5. 5.
    Clifford B.D., Donahue D., Smith L., Cable E., Luttig B., Manns M., Bonkovsky H.L. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995, 21: 613–619.PubMedGoogle Scholar
  6. 6.
    Mandrup-Poulsen T., Nerup J., Reimers J.I., Pociot F., Andersen H.U., Karlsen A., Bjerre U., Bergholdt R. Cytokines and the endocrine system. 2. Roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine diseases. Eur. J. Endocrinol. 1996, 134: 21–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Lunel F. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 1994, 108: 1334.Google Scholar
  8. 8.
    Heathcote E.J. Autoimmune hepatitis and chronic hepatitis C: latent or initiated by interferon therapy? Gastroenterology 1995, 108: 1942.PubMedCrossRefGoogle Scholar
  9. 9.
    Nagayama Y., Ohta K., Tsuruta M., Takeshita A., Kimura H., Hamasaki K., Ashizawa K., Nakata K., Yokoyama N., Nagataki S. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: Our studies and review of the literature. Endocrinol. J. 1994, 41: 565–572.Google Scholar
  10. 10.
    Pateron D., Hartmann D.J., Duclosvallee J.C., Jouanolle H., Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J. Hepatol. 1993, 17: 417–419.PubMedCrossRefGoogle Scholar
  11. 11.
    Preziati D., La Rosa L., Covini G., Marcelli R., Rescalli S., Persani L., Del Ninno E., Meroni P.L., Colombo M., Beck-Peccoz P. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur. J. Endocrinol. 1995, 132: 587–593.PubMedCrossRefGoogle Scholar
  12. 12.
    Custro N., Montalto G., Scafidi V., Soresi M., Gallo S., Tripi S., Notarbartolo A. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J. Endocrinol. Invest. 1997, 20: 374–380.PubMedGoogle Scholar
  13. 13.
    Fernandez-Soto L., Gonzalez A., Escobar-Jimenez F., Vazquez R., Ocete E., Olea N., Salmeron J. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch. Intern. Med. 1998, 158: 1445–1448.PubMedCrossRefGoogle Scholar
  14. 14.
    Olivieri A., Sorcini M., Battisti P., Fazzini C., Gilardi E., Sun Y., Medda E., Grandolfo M., Tossini G., Natili S., Gioia C., Narciso P., Visco G., Carta S. Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J. Endocrinol. Invest. 1993, 16: 407–413.PubMedGoogle Scholar
  15. 15.
    Huang M.J., Wu S.S., Liaw Y.F. Thyroid abnormalities in patients with chronic viral hepatitis. Hepatology 1994, 20: 1651–1652.PubMedCrossRefGoogle Scholar
  16. 16.
    Marazuela M., Garcia-Buey L., Gonzalez-Fernandez B., Garcia-Monzon C., Arranz A., Borque M.J., Moreno-Otero R. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin. Endocrinol. (Oxf). 1996, 44: 635–642.PubMedCrossRefGoogle Scholar
  17. 17.
    Duclos-Vallée J.C., Johanet C., Trinchet J.C., Deny P., Laurent M.F., Duron F., Valensi P., Weil B., Homberg J.C., Pateron D., Beaugrand M. High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto’s thyroiditis. BMJ 1994, 309: 846–847.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Wagner B., Vierhapper H., Hofmann H. Prevalence of hepatitis C virus infection in Hashimoto’s thyroiditis. BMJ 1996, 312: 640–641.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Wong S., Mehta A.E., Faiman C., Berard L., Ibbott T., Minuk G.Y. Absence of serologic evidence for hepatitis C virus infection in patients with Hashimoto’s thyroiditis. Hepatogastroenterology 1996, 43: 420–421.PubMedGoogle Scholar
  20. 20.
    Boadas J., Rodriguez-Espinosa J., Enriquez J., Miralles F., Martinez-Cerezo F.J., Gonzalez P., Madoz P., Vilardell F. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J. Hepatol. 1995, 22: 611–615.PubMedCrossRefGoogle Scholar
  21. 21.
    Farci P., Orgiana G., Coiana A., Peddis G., Mandas A., Lai M.E., Farci A.M.G., Chessa L., Balestrieri A. Epidemiology of HDV infection in Sardinia, an island with high endemicity for HBV: a multicenter study. In: Gerin J.L., Purcell R.H., Rizzetto M., (Eds), Progress in Clinical and Biological Research, the Hepatitis Delta Virus. Alan Liss, Inc., New York, 1991, p.40–50.Google Scholar
  22. 22.
    Muntoni S., Songini M. Sardinian Collaborative Group for Epidemiology of IDDM: high incidence of IDDM in Sardinia. Diabetes Care 1992, 15: 1317–1322.PubMedCrossRefGoogle Scholar
  23. 23.
    Marrosu M.G., Muntoni F., Murru M.R., Costa G., Pischedda M.P., Pirastu M., Sotgiu S., Rosati G., Cianchetti C. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles. Neurology 1992, 42: 883–886.PubMedCrossRefGoogle Scholar
  24. 24.
    Mariotti S., Caturegli P., Piccolo P., Barbesino G., Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. J. Clin. Endocrinol. Metab. 1990, 71: 661–669.PubMedCrossRefGoogle Scholar
  25. 25.
    Di Mario U., Betterle C., Dondero F., Fenzi G.F., Mariotti S., Trimarchi F. Italian serum exchange workshop for the standardization of organ specific autoantibodies. J. Endocrinol. Invest. 1994, 17: 355–365.PubMedGoogle Scholar
  26. 26.
    Lai M.E., Mazzoleni A.P., Farci P., Melis A., Porru A., Orgiana G., Arnone M., Balestrieri A. Markers of hepatitis C virus infection in sardinian blood donors: relationship with alanine aminotransferase levels. J. Med. Virol. 1993, 41: 282–288.PubMedCrossRefGoogle Scholar
  27. 27.
    Rosner B. Fundamental of Biostatistics. Duxbury Press Inc., Boston, 1986.Google Scholar
  28. 28.
    Miettinen O. Estimability and estimation in case-referent studies. Am. J. Epidemiol. 1976, 103: 226–235.PubMedGoogle Scholar
  29. 29.
    Tillmann H.L., Manns M.P. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig. Dis. Sci. 1996, 41: 27, 27S–40S.PubMedCrossRefGoogle Scholar
  30. 30.
    Tunbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Grimley Evans J., Young E., Bird T., Smith P.A. The spectrum of thyroid disease in a community: the Wickham survey. Clin.Endocrinol. (Oxf). 1977, 7: 481–493.CrossRefGoogle Scholar
  31. 31.
    Hawkins B.R., Cheah P.S., Dawkins R.L., Whittingham S., Burger H.G., Patel Y., Mackay I.R., Welborn T.A. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980, 2: 1057–1059.PubMedCrossRefGoogle Scholar
  32. 32.
    Konno N., Yuri K., Taguchi H., Miura K., Taguchi S., Hagiwara K., Murakami S. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. (Oxf). 1993, 38: 273–281.PubMedCrossRefGoogle Scholar
  33. 33.
    Salabè-Lotz H., Salabè G.B. Population survey of thyroid autoimmunity in Italy. Three-year follow up. Thyroidology 1990, 2: 107–112.PubMedGoogle Scholar
  34. 34.
    Mariotti S., Sansoni P., Barbesino G., Caturegli P., Monti D., Cossarizza A., Giacomelli T., Passeri G., Fagiolo U., Pinchera A., Franceschi C. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992, 339: 1506–1508.PubMedCrossRefGoogle Scholar
  35. 35.
    Quaranta J.F., Tran A., Regnier D., Letestu R., Beusnel C., Fuzibet J.G., Thiers V., Rampal P. High prevalence of antibodies to hepatitis-C virus (HCV) in patients with anti-thyroid autoantibodies. J. Hepatol 1993, 18: 136–138.PubMedCrossRefGoogle Scholar
  36. 36.
    Baudin E., Marcellin P., Pouteau M., Colas-Linhart N., Lefloch J.P., Lemmonier C., Benhamou J.P., Bok B. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocrinol. (Oxf). 1993, 39: 657–661.PubMedCrossRefGoogle Scholar
  37. 37.
    Colas-Linhart N., Bok B., Marcellin P., Pouteau M., Benhamou J.P. Anti-thyroid autoantibodies and hepatitis C virus. Hepatology. 1994, 20: 1649.PubMedCrossRefGoogle Scholar
  38. 38.
    Czaja A.J., Carpenter H.A., Santrach P.J., Moore S.B. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J. Hepatol. 1996, 24: 52–59.PubMedCrossRefGoogle Scholar
  39. 39.
    Metcalfe R.A., Ball G., Kudesia G., Weetman A.P. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid 1997, 7: 421–424.PubMedCrossRefGoogle Scholar
  40. 40.
    Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., Ruol A. Hepatitis C viraemia and liver disease in symptomfree individuals with anti-HCV. Lancet 1992, 340: 697–698.PubMedCrossRefGoogle Scholar
  41. 41.
    Bortolotti F., Vajro P., Balli F., Giacchino R., Crivellaro C., Barbera C., Cataleta M., Mratori L., Pontisso P., Nebbia G., Zancan L., Bertolini A., Alberti A., Bianchi F. Non-organ specific autoantibodies in children with chronic hepatitis C. J. Hepatol. 1996, 25: 614–620.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1999

Authors and Affiliations

  • A. Loviselli
    • 1
  • A. Oppo
    • 1
  • F. Velluzzi
    • 1
  • F. Atzeni
    • 1
  • G. L. Mastinu
    • 2
  • P. Farci
    • 3
  • G. Orgiana
    • 3
  • A. Balestrieri
    • 3
  • P. L. Cocco
    • 4
  • S. Mariotti
    • 1
  1. 1.Cattedra di Endocrinologia, Dipartimento di Scienze Mediche “M. Aresu”Università di CagliariCagliariItaly
  2. 2.Ospedale di OzieriOzieriItaly
  3. 3.Unità di Epatologia, Dipartimento di Scienze Mediche “M. Aresu”Università di CagliariItaly
  4. 4.Istituto di Medicina del LavoroUniversità di CagliariCagliariItaly

Personalised recommendations